Clinical Trial Update: Pre-Operative Intravitreal Bevacizumab for Tractional Retinal Detachment Secondary to Proliferative Diabetic Retinopathy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating pre-operative intravitreal bevacizumab for tractional retinal detachment due to proliferative diabetic retinopathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tractional Retinal Detachment Secondary to Proliferative Diabetic Retinopathy

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: J. Fernando Arevalo, MD FACS | Conditions: Tractional Retinal Detachment Secondary to Proliferative Diabetic Retinopathy | Phase 3 | Status: COMPLETED